Raluca Alexandru

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

CD137 agonists in mice suppress germinal center responses by increasing the immunosuppressive activity of follicular regulatory T-cells.

CD137 agonists in mice suppress germinal center responses by increasing the immunosuppressive activity of follicular regulatory T-cells.

Journal: The EMBO journal

Published: January 04, 2026

CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

CD70 Overexpression at Diagnosis Predicts Relapse and supports dual CD19-CD70 CAR-T Therapy in Follicular Lymphoma.

Journal: Blood

Published: December 05, 2025

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

TNFR1 expression on cancer cells mediates immune escape and an immunosuppressive microenvironment.

Journal: The Journal of experimental medicine

Published: October 08, 2025

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer.

Conventional type-1 DC density is associated with checkpoint inhibitor response across multiple types of cancer.

Journal: The Journal of clinical investigation

Published: October 07, 2025

The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas.

The Proteomic Landscape of CTNNB1 Mutated Low-Grade Early-Stage Endometrial Carcinomas.

Journal: Cells

Published: September 17, 2025

Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: July 05, 2025

Comprehensive Spatial Methods (CSM): a Toolbox for Spatially Analyzing Tissues in Histopathology.

Comprehensive Spatial Methods (CSM): a Toolbox for Spatially Analyzing Tissues in Histopathology.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: June 04, 2025

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: January 31, 2025

MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers.

MHC class I and II-deficient humanized mice are suitable tools to test the long-term antitumor efficacy of immune checkpoint inhibitors and T-cell engagers.

Journal: Journal for immunotherapy of cancer

Published: August 09, 2024

CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Journal: Science advances

Published: August 18, 2023

Showing 1-10 of 10

Last Updated: 09/26/2026